Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $13.4200 (-4.96%) ($13.3600 - $14.3300) on Wed. Sep. 23, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.05% (three month average) | RSI | 58 | Latest Price | $13.4200(-4.96%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -3% a day on average for past five trading days. | Weekly Trend | ATRA advances 4.4% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(53%) ARKG(44%) IBB(44%) IWO(44%) ARKK(43%) | Factors Impacting ATRA price | ATRA will decline at least -2.025% in a week (0% probabilities). VIXM(-32%) VXX(-26%) UNG(-10%) UUP(-9%) TLT(-7%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.025% (StdDev 4.05%) | Hourly BBV | 0 () | Intraday Trend | -5.3% | | | |
|
Resistance Level | $14.2 | 5 Day Moving Average | $14.81(-9.39%) | 10 Day Moving Average | $14.95(-10.23%) | 20 Day Moving Average | $14.2(-5.49%) | To recent high | -15.4% | To recent low | 12.6% | Market Cap | $997m | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |